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Background: There is growing interest in the use of blood components for pre-hospital resuscitation of patients
with major traumatic haemorrhage. It has been speculated that early resuscitation with blood components may
have benefits in terms of treating trauma-induced coagulopathy, which in turn may influence survival. The proposed
systematic review will evaluate the evidence on the clinical effectiveness of pre-hospital blood components (red blood
cells and/or plasma or whole blood), in both civilian and military settings, compared with other resuscitation strategies
in patients with major traumatic haemorrhage.
Methods/design: Standard systematic review methods aimed at minimising bias will be employed for study
identification, selection and data extraction. General medical and specialist databases will be searched; the
search strategy will combine terms for the population, intervention and setting. Studies will be selected for
review if the population includes adult patients with major traumatic haemorrhage who receive blood components in
a pre-hospital setting (civilian or military). Systematic reviews, randomised and non-randomised controlled trials and
controlled observational studies will be included. Uncontrolled studies will be considered depending on the volume of
controlled evidence. Quality assessment will be tailored to different study designs. Both patient related and surrogate
outcomes will be considered. Synthesis is likely to be primarily narrative, but meta-analyses and subgroup analyses will
be undertaken where clinical and methodological homogeneity exists.
Discussion: Given the increasing use by emergency services of blood components for pre-hospital resuscitation, this is
a timely systematic review, which will attempt to clarify the evidence base for this practice. As far as the authors are
aware, the proposed systematic review will be the first to address this topic.
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The in-hospital resuscitation of patients suffering from
major traumatic haemorrhage has undergone a revolu-
tion over recent years, with the previous mainstay of
resuscitation—crystalloid—being replaced by blood com-
ponent therapy. Observational evidence from both mili-
tary and civilian practice suggests a survival benefit from
resuscitation with high ratios of plasma to packed red
blood cells (pRBC) (so-called “haemostatic resuscitation”
(HR)) [1,2]. It has been suggested that early use of blood
products rather than crystalloids may convey a survival
advantage, perhaps due to improved oxygen-carrying
capacity, more effective volume expansion and by lessen-
ing the coagulopathy of trauma [3,4].
The pre-hospital setting is more complex. A previous
randomised controlled trial [5] demonstrated that pre-
hospital crystalloid resuscitation increased mortality and
morbidity in patients who had suffered penetrating trauma.
It is believed that early aggressive volume administration
may lead to “clot blow-off”, i.e. clots dislodged due to in-
creased arterial pressure, and rebleeding. Consequently,
pre-hospital resuscitation moved towards restricted fluid
regimes.
Military experience has proven that it is feasible and
practical to provide blood products for transfusion in
the pre-hospital arena [6]. Anecdote and limited obser-
vational evidence from British military casualty retrieval
missions suggest a potential survival benefit from pre-
hospital HR [7,8] but are confounded by factors such as
increasingly liberal in-hospital transfusion practices [9].
However, a large observational study of pre-hospital
blood products failed to identify any reduction in mortality
or coagulopathy [10]. This is consistent with a civilian in-
hospital study which suggested that HR’s effect is
dependent on surgical haemorrhage control [11]. Other
confounders of military studies include incomplete data
(due to the nature of the combat environment) and inabil-
ity to follow up patients—particularly those of other na-
tionalities—following discharge. The military population is
younger, almost exclusively male and fitter, with minimal
comorbidity compared to civilian trauma patients. Mecha-
nisms of injury differ; over 95% of severe battlefield
trauma results from explosive events or gunshot from
military weapons [10]—mechanisms almost unknown in
UK civilian practice and rare in other countries. Conse-
quently, perceived benefits from military pre-hospital can-
not be assumed to translate directly to civilian practice.
Nonetheless, an increasing number of civilian pre-
hospital retrieval services are carrying pRBCs for trauma
resuscitation, which has significant cost and logistical
implications. Pilot studies [12-14] have demonstrated
the feasibility of pre-hospital pRBC use with complete
traceability and minimal wastage (0.0%–1.6%), with no
early transfusion reactions recorded. Studies on theeffectiveness of pre-hospital pRBC [3,15,16] or plasma
[17] transfusion in a civilian population suggest a bene-
fit; however, these findings are limited by factors includ-
ing retrospective design, non-standardised care and
insufficient statistical power. There are at least two rele-
vant ongoing randomised controlled trials [18,19].
Despite the existence of a number of primary studies
as outlined above, a scoping search identified no existing
systematic reviews. A systematic review [20] on all as-
pects of the acute management of trauma from 2011
was limited to RCTs and did not find any relevant stud-
ies. US guidelines from 2009 [21] had a limited search
strategy, and searches were performed in 2007; this re-
port included two potentially relevant primary studies
[22,23]. A narrative review from 2013 [24] with a limited
search strategy identified only one relevant study [12].
Pre-hospital resuscitation with blood components has
already been adopted as routine practice in some emer-
gency services. Urgent clarification of the evidence base
is required. The aim is therefore to undertake a system-
atic review of the evidence on the clinical effectiveness
of pre-hospital blood components (red blood cells and/
or plasma or whole blood), in both civilian and military
settings, compared with other resuscitative fluids in pa-
tients with major traumatic haemorrhage.
Methods/design
Standard systematic review methodology aimed at mini-
mising bias will be employed, and reporting will follow the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines [11]. This protocol is
registered with PROSPERO (CRD42014013794).
Searches
The following sources will be searched for primary
studies:
 Bibliographic databases—MEDLINE, MEDLINE In
Process and EMBASE via Ovid and The Cochrane
Library (CENTRAL databases)
 UK Blood Services Transfusion Evidence Library
 Defence Medical Library Service (Ministry of Defence)
 Science Citation Index (ISI) for citation searching
 Current controlled trials (www.controlled-trials.com/),
WHO International Clinical Trials Registry
Platform (ICTRP) and ClinicalTrials.gov for
ongoing studies
 Specialist abstract and conference proceeding
resources (British Library’s ZETOC and ISI
Proceedings)
 Checking of citation lists of included studies and
relevant reviews
 Contact with study authors and researchers of
ongoing trials
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Trauma Hemostasis and Oxygenation Research
Network, the Cochrane Pre-hospital and Emergency
Care group)
 Hand searching may be performed for relevant
conference abstract books
A combination of alternative text and MeSH terms re-
lating to the condition (haemorrhage), intervention (blood
components) and setting (pre-hospital) will be utilised.
There will be no language restrictions applied to the
searches. Given that the number of relevant primary stud-
ies is likely to be small, and the study design (terminology)
variable, searches will be broad and study design filters will
not be used. There will also be no restriction of searches
by comparators or outcomes. A sample search strategy for
MEDLINE is provided in Additional file 1.
Search results will be entered into electronic databases
(EndNote version X7.1, Thomson Reuters, New York) to
facilitate record keeping, duplicate removal, study selec-
tion and document writing. Titles (and abstracts where
available) of articles identified by the searches will be
screened by two reviewers, independently, for relevance
to the review question using pre-specified screening
criteria. This process will be aimed at removing non-
relevant studies. Full text copies of potentially relevant
articles will be acquired and assessed independently
against the inclusion criteria by two reviewers. Discrep-
ancy between reviewers will be resolved by discussion or
by referring to a third reviewer. Where necessary, trans-
lation (full/part) of non-English language articles will be
undertaken to facilitate this process and subsequent
reviewing; the review team has access to a wide range of
translators. The study selection process will be illustrated
using a PRISMA flow diagram. Reference management
software will be used to record reviewer decisions, includ-
ing reasons for exclusion.
Selection criteria
Study design
Based on scoping searches, relevant studies are most
likely to be (retrospective) cohorts or uncontrolled
studies (case series). Inclusion of studies will be limited in
the first instance to controlled studies (randomised or
non-randomised, prospective or retrospective, concomi-
tant or historical control). It is likely that evidence from
controlled studies will be limited (≤10 studies); if this
is the case, inclusion will be extended to uncontrolled
studies.
Patient group
The patient group will be individuals aged ≥16 with
major traumatic haemorrhage with hypotension (as de-
fined by study authors). There will be no restriction ontype, mechanism or location of injury, or co-existing
conditions.
Intervention
Any blood components likely to be administered in a pre-
hospital setting, including the following: whole blood, RBCs
alone, RBCs and plasma (any ratio) or plasma alone.
Comparator (for controlled studies)
Any other resuscitative fluid (e.g. crystalloids, colloids)
or any of the interventions compared against each other,
with or without additional agents such as tranexamic
acid.
Setting
The setting is pre-hospital, i.e. administration of fluids at
the point of injury or in transit to hospital (ground or
air transport). Both civilian and military environments
will be eligible.
Outcomes
There will be no restriction by outcome. The primary
outcome of interest is survival; however, studies are
unlikely to be powered to show any differences. The
following (secondary) outcomes will therefore also be
considered:
 Lactate concentration
 Blood gases
 Measures of coagulopathy
 Additional blood components (or other fluids) given
in hospital
 Organ failure
 Infection
 Adverse events associated with intervention
 Outcomes relating to the feasibility of using blood
components in a pre-hospital setting (e.g. wastage
and transfusion reactions)
Data extraction
Data extraction will be conducted by one reviewer using
a standardised, piloted data extraction form and checked
by a second reviewer. Disagreements will be resolved
through discussion or referral to a third reviewer. For
each study, the data required on (but not limited to) the
following will be sought:
Study characteristics
 Country of origin
 Study design
 Setting (civilian or military)
 Sample size
 Length of follow-up
Dretzke et al. Systematic Reviews 2014, 3:123 Page 4 of 6
http://www.systematicreviewsjournal.com/content/3/1/123Population
 Patient inclusion and exclusion criteria (including
definition of hypotension)
 Location, mechanism and severity of injury (e.g. as
defined by the Injury Severity Score or New Injury
Severity Score)
Intervention/comparator
 Combination/ratio of blood components and
quantity administered
 Comparator fluid and quantity administered
 Location of administration (e.g. at the scene or
in transit)
 Characteristics/training of individual administering
fluids
Results
 Completeness of follow-up
 Outcome measures
 Statistical methods employed (e.g. for adjusting for
confounders)
 Findings
 Effect sizes and associated uncertainty
Quality assessment
Data will be extracted to allow quality assessment of the
included studies. Quality assessment will be based on
tools specific to a given study design.
For randomised and non-randomised controlled trials
(should any be identified), quality assessment will be
based on the risk of bias tool from the Cochrane Hand-
book [25]. The Newcastle-Ottawa Scale (NOS) [26] will
be used for cohort or case-control studies. Some of the
confounding factors likely to arise in non-randomised
studies include the following: severity and mechanism of
injury, distance between site of injury and hospital,
transportation time, co-interventions, characteristics of
individual administering fluids and adherence to fluid
protocols. When assessing study quality, the extent to
which confounders have been given adequate consider-
ation, both in reporting and analysis, will be examined.
For uncontrolled observational studies, details will be
sought on population characteristics (including repre-
sentativeness and eligibility criteria), intervention and
adequacy of assessment of relevant outcomes and of
follow-up (e.g. at least 30 days for survival (civilian
population) or up to point of discharge to other health-
care service (military population)).
In addition to the methodological criteria listed above,
the GRADE [27] framework may be used to consider in-
consistency between studies, precision of results, likelihoodof publication bias and applicability of results to popula-
tion(s) of interest.
Analysis
Narrative synthesis of evidence will be undertaken for all
included studies. This will include a narrative descrip-
tion and tabulation of main results across studies and/or
for specific outcomes. Visual representation of results in
Forest plots without pooling may also be considered.
Summary measures for the main outcome of interest,
survival, may be in the form of relative risk or hazard
ratio (adjusted or unadjusted). For other outcomes (e.g.
lactate concentration), mean differences (adjusted or un-
adjusted) may be reported. Based on preliminary find-
ings, it is unlikely that there will be sufficient (similar)
studies to conduct meta-analysis; however, appropriate
meta-analytic methods will be employed where possible
to combine data from similar studies. Assessment of
clinical and methodological heterogeneity will be used to
determine whether a fixed or random effects model is
the most appropriate, rather than relying on the tests of
heterogeneity from a fixed effect model to make such a
decision [28]. The I2 statistic (which gives the percentage
of the total variability in the data due to between-study
heterogeneity) and the tau-squared statistic (which gives
an estimate of the between-study variance) will be re-
ported where appropriate. Where studies have reported
time-to-event analyses, meta-analysis using the extracted
hazard ratios and their variances will be undertaken, if
possible. Evidence from studies of different design will
not be quantitatively combined, but presented separately.
Any adjusted and unadjusted results will also be pre-
sented separately. Presentation of results in Forest plots
without a pooled summary estimate will be considered
where pooling is not feasible.
For each meta-analysis containing 10 or more studies,
the likelihood of publication bias will be investigated
through the construction of funnel plots and appropriate
statistical tests for small-study effects (such as the Peters
Test [29]); that is, the tendency for smaller studies to
provide more positive findings. It is well recognised that,
especially where heterogeneity exists, publication bias
may be one of a number of reasons for any small-study
effects identified.
Subgroup analysis
Subgroup analysis may include examining studies separ-
ately depending on pre-hospital setting (military or civil-
ian) or where there is clear clinical heterogeneity
between studies (e.g. in intervention/comparator, patient
characteristics etc.). The robustness of any meta-analysis
conclusions to the inclusion/exclusion of low quality
studies (i.e. those at most risk of bias) may be assessed if
feasible.
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Emergency services, both in the UK and internationally,
are already increasingly incorporating the use of blood
components into pre-hospital resuscitation protocols for
major traumatic haemorrhage. As far as the authors are
aware, however, there have been no attempts to formally
review the evidence base, and a systematic review is
therefore urgently required. Whilst some studies appear
to show benefits of pre-hospital blood components,
there are methodological issues associated with many
studies, which are mainly of a retrospective observa-
tional design. A thorough evaluation of study method-
ology and risk of bias as part of the proposed systematic
review will not only help to make an assessment of the
robustness of findings but may also help to inform fu-
ture study design. Further, an assessment of the extent
of transferability of findings from military research to a
civilian population will be of interest, both for this sys-
tematic review question and potentially for other areas
of trauma medicine.
Additional file
Additional file 1: Sample search strategy. Sample search strategy to
identify relevant primary studies in MEDLINE.
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